Solid Biosciences is trading at $10.23, up 5.25%, primarily amid a strong growth-stock rally.
- Nasdaq is up 1.33%, while the S&P 500 is up 0.53%.
- No new company-specific announcement, earnings release, regulatory decision, or analyst downgrade was identified for August 27, 2026.
- The latest company disclosure remains the August 6 second-quarter update; the move appears primarily market-driven rather than catalyst-specific.